SEC Form 4 · accession 0001078782-19-000006
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Dec 11, 2018
Accepted (ET)
Jan 3, 2019 · 3:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 11, 2018 | P | 12,000 | $0.14 | A | 20,342,520 | D | |
| Common Stock | Dec 12, 2018 | P | 35,000 | $0.13 | A | 20,377,520 | D | |
| Common Stock | Dec 13, 2018 | P | 85,000 | $0.12 | A | 20,462,520 | D | |
| Common Stock | Dec 14, 2018 | P | 40,000 | $0.12 | A | 20,502,520 | D | |
| Common Stock | Dec 17, 2018 | P | 59,000 | $0.13 | A | 20,561,520 | D | |
| Common Stock | Dec 18, 2018 | P | 91,000 | $0.13 | A | 20,652,520 | D | |
| Common Stock | Dec 19, 2018 | P | 15,000 | $0.13 | A | 20,667,520 | D | |
| Common Stock | Dec 20, 2018 | P | 46,000 | $0.13 | A | 20,713,520 | D | |
| Common Stock | Dec 21, 2018 | P | 15,000 | $0.13 | A | 20,728,520 | D | |
| Common Stock | Dec 24, 2018 | P | 60,000 | $0.11 | A | 20,947,520 | D | |
| Common Stock | Dec 27, 2018 | P | 75,000 | $0.12 | A | 21,022,520 | D | |
| Common Stock | Dec 28, 2018 | P | 106,000 | $0.11 | A | 21,128,520 | D | |
| Common Stock | Dec 31, 2018 | P | 72,500 | $0.13 | A | 21,201,020 | D | |
| Common Stock | Jan 2, 2019 | P | 13,000 | $0.13 | A | 21,214,020 | D |
Table II — derivative securities
No Table II lines on this filing.